Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Melanoma × Observation × Clear all

Phase

Phase 3 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Squamous Intraepithelial Lesions 1 Sezary Syndrome 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphedema of Face 1 Lung Neoplasms 1

Interventions

Blood Specimen Collection 11 Radiosurgery 7 Surveys and Questionnaires 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 4 Educational Status 4 Early Intervention, Educational 4 Surgical Procedures, Operative 3 Nivolumab 3 Ipilimumab 3 Indocyanine Green 3 Biopsy 3 pembrolizumab 2 aldesleukin 2 X-Rays 2 Tomography, X-Ray Computed 2 Sentinel Lymph Node Biopsy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 Immunotherapy 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Diathermy 2 Dermoscopy 2 Cyclophosphamide 2 Cognitive Behavioral Therapy 2 toripalimab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00975520 2024-11-27

RTN2

Melanoma and Skin Cancer Trials Limited

Phase NA Completed

Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡